M
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Price:
121.2
SAR
1.68%
Market Closed
Market Cap:
﷼2.4B
Relative Value
The Relative Value of one Middle East Pharmaceutical Industries Company SJSC stock under the Base Case scenario is hidden SAR. Compared to the current market price of 121.2 SAR, Middle East Pharmaceutical Industries Company SJSC is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Middle East Pharmaceutical Industries Company SJSC Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Middle East Pharmaceutical Industries Company SJSC Competitors
Middle East Pharmaceutical Industries Company SJSC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SA |
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
2.4B SAR | 5.3 | 25 | 19.2 | 22.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
863B USD | 13.3 | 42.1 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
572.1B USD | 6.1 | 21.3 | 14.8 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
250.6B CHF | 4.1 | 19.5 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.8B GBP | 5 | 28.7 | 15.9 | 22.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
226.1B CHF | 5.2 | 20.8 | 12.9 | 16.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.5B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
240.1B USD | 103.6 | -82.1 | 380.1 | 953.2 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.7B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.3B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
